We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
NF-kappaB and IKK as therapeutic targets in cancer.
- Authors
Kim, H J; Hawke, N; Baldwin, A S
- Abstract
The transcription factor NF-kappaB and associated regulatory factors (including IkappaB kinase subunits and the IkappaB family member Bcl-3) are strongly implicated in a variety of hematologic and solid tumor malignancies. A role for NF-kappaB in cancer cells appears to involve regulation of cell proliferation, control of apoptosis, promotion of angiogenesis, and stimulation of invasion/metastasis. Consistent with a role for NF-kappaB in oncogenesis are observations that inhibition of NF-kappaB alone or in combination with cancer therapies leads to tumor cell death or growth inhibition. However, other experimental data indicate that NF-kappaB can play a tumor suppressor role in certain settings and that it can be important in promoting an apoptotic signal downstream of certain cancer therapy regimens. In order to appropriately move NF-kappaB inhibitors in the clinic, thorough approaches must be initiated to determine the molecular mechanisms that dictate the complexity of oncologic and therapeutic outcomes that are controlled by NF-kappaB.
- Publication
Cell death and differentiation, 2006, Vol 13, Issue 5, p738
- ISSN
1350-9047
- Publication type
Journal Article
- DOI
10.1038/sj.cdd.4401877